catalog number :
MBS539422
products type :
Recombinant Protein
products full name :
IGF BP3 protein
products short name :
IGF BP3
products name syn :
IGF BP-3 protein; Insulin-like Growth Factor-Binding Protein 3 protein; Growth-hormone-dependant binding protein protein; IGF BP-3; IGF BP 3 protein; IGF BP 3; IGF BP3
other names :
insulin-like growth factor-binding protein 3 isoform a; Insulin-like growth factor-binding protein 3; insulin-like growth factor-binding protein 3; insulin-like growth factor binding protein 3
products gene name :
IGF BP3
other gene names :
IGFBP3; IGFBP3; IBP3; BP-53; IBP3; IBP-3; IGF-binding protein 3; IGFBP-3
uniprot entry name :
IBP3_HUMAN
sequence :
Region of IGF BP3 protein corresponding to amino acids GASSGGLGPV VRCEPCDARA LAQCAPPPAV CAELVREPGC GCCLTCALSE GQPCGIYTER CGSGLRCQPS PDEARPLQAL LDGRGLCVNA SAVSRLRAYL LPAPPAPGNA SESEEDRSAG EVESPSVSST HRVSDPKFHP LHSKIIIIKK GHAKDSQRYK VDYESQSTDT QNFSSESKRE TEYGPCRREM EDTLNHLKFL NVLSPRGVHI PNCDKKGFYK KKQCRPSKGR KRGFCWCVDK YGQPLPGYTT KGKEDVHCYS MQSK.
form :
Lyophilized from 20 mM NaCl. Reconstitute in water to a concentration of 0.1 - 1.0 mg/ml.
storage stability :
Store at 4 degree C until reconstitution. Following reconstitution aliquot and freeze at -20 degree C for long term storage. Avoid repeated freeze/thaw cycles.
tested application :
User optimized
other info1 :
Protein Type: Recombinant. Biological Significance: IGF-BP3 is a 30 kDa cysteine-rich secreted protein. It is the major IGF binding protein present in the plasma of human and animals and it is also found in a-granules of platelets. In addition to its ability to modulate the activity of IGF-I and IGF-II, IGF-BP3 exerts inhibitory effects on follicle stimulating hormone (FSH) activity. Decreased plasma levels of IGF-BP3 often results in dwarfism, whereas elevated levels of IGF-BP3 may lead to acromegaly. The expression of IGF-BP3 in fibroblasts is stimulated by mitogenic growth factors such as Bombesin, Vasopressin, PDGF, and EGF. Bioactivity: The ED50 was determined by its ability to inhibit IGF-II induced proliferation of MCF-7. The expected ED50 for this effect is approximately 0.2 ug/ml in presence of 15 ng/ml of human IGF-II. Endotoxin Levels: Endotoxin level is less than 0.1 ng per ug (1 EU/ug).
other info2 :
Expression System: E Coli
products categories :
Cytokines & Growth Factors
products description :
Purified recombinant Human IGF BP3 protein
ncbi acc num :
NP_001013416.1
ncbi gb acc num :
NM_001013398.1
ncbi mol weight :
28.8 kDa
ncbi pathways :
Direct P53 Effectors Pathway 137939!!Integrated Pancreatic Cancer Pathway 711360!!Metabolism Of Proteins Pathway 106230!!Myometrial Relaxation And Contraction Pathways 198759!!Regulation Of Insulin-like Growth Factor (IGF) Transport And Uptake By Insulin-like Growth Factor Binding Proteins (IGFBPs) Pathway 105908!!Senescence And Autophagy Pathway 198780!!Transcriptional Misregulation In Cancer Pathway 523016!!Transcriptional Misregulation In Cancer Pathway 522987!!P53 Signaling Pathway 83055!!P53 Signaling Pathway 465
ncbi summary :
This gene is a member of the insulin-like growth factor binding protein (IGFBP) family and encodes a protein with an IGFBP domain and a thyroglobulin type-I domain. The protein forms a ternary complex with insulin-like growth factor acid-labile subunit (IGFALS) and either insulin-like growth factor (IGF) I or II. In this form, it circulates in the plasma, prolonging the half-life of IGFs and altering their interaction with cell surface receptors. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]